News
RK Asset Management boosted its stake in Regeneron Pharmaceuticals by 25.8%, bringing its total to 12,563 shares worth $7.97 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback